Bromocriptine treatment of nonfluent aphasia.

Machine translation Machine translation
作者
类别 Primary study
期刊Neurology
Year 1995
一项双盲,安慰剂对照,交叉设计,我们研究了20名男性慢性非流利性失语溴隐亭(每天15毫克)。这项研究进行了28周的时间,分两个阶段进行。在第一阶段,患者接受溴隐亭或安慰剂,在第二阶段的治疗越过。我们评估每个病人的语言和非语言认知技能的每一个阶段和6周后完成第二阶段的开始和结束。与安慰剂治疗相比,溴隐亭并没有显著改善患者的言语流畅性,语言的内容,总体程度的失语的严重程度,或者非语言的认知能力。基于这些结果,溴隐亭是不建议作为单一疗法治疗慢性非流利性失语。
Epistemonikos ID: aec14388b383d5aa770bde388e617e7c9732a217
First added on: Feb 01, 2013
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use